RWE: Cost and Time Savings Entice Sponsors as Pitfalls Linger

The New England Journal of Medicine published an article earlier this week raising questions about the use of observational real world evidence (RWE), and how part of this drive toward using nonrandomized studies to assess the effects of treatments is due to the expensive and complex way that randomized clinical trials are being conducted.